Full data view for gene FH

Information The variants shown are described using the NM_000143.3 transcript reference sequence.

5 entries on 1 page. Showing entries 1 - 5.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

Protein     

Zygosity     

Co_ocurrence     

RNA change     

Review status     

Allele     

DNA change (genomic) (hg38)     

Reference     

DB-ID     

dbSNP ID     

Variant remarks     

Template     

Technique     

Date of test     

Lab     

Remarks     

Type of test     

Disease     

Ethnic origin     

Reference     

Remarks     

Cuadro familiar     

Panel size     

Owner     
-/- 7 c.927G>A p.(=) Hetero no r.(=) - Unknown g.241504223C>T - FH_000002 - - DNA SEQ-NG 7-aug-2018 CEMIC - Specific pathology Kidney cancer Italian - CIA (pnales/explica cuadro clínico) Kidney cancer 1 Jesica Ramirez-Hospital Central de Mendoza
?/+? 8 c.1157A>C p.(Gln386Pro) Hetero no r.(?) - Unknown g.241502522T>G - FH_000001 - - DNA SEQ-NG 7-aug-2018 CEMIC - Specific pathology Kidney cancer Italian - CIA (pnales/explica cuadro clínico) Kidney cancer 1 Jesica Ramirez-Hospital Central de Mendoza
-?/-? 8i c.1237-14_1237-13dup p.(=) Hetero no r.(=) - Unknown g.241500603_241500604dup - FH_000003 - - DNA SEQ-NG 25-mar-2019 CEMIC - Multigenetic panel - Syrian-Basque-Italian - - - 1 Pablo Kalfayan-Hospital Italiano
?/? 10 c.1431_1433dup p.(Lys477dup) Hetero no r.(?) - Unknown g.241497928_241497930dup - FH_000004 - This is an in-frame duplication that has been observed with several different pathogenic FH variants in multiple affected individuals with FHD. In the homozygous state, this variant does not likely cause FHD, but additional data are needed to prove that conclusively. Although it has been observed as heterozygous in individuals with features of HLRCC, it occurs in the general population too frequently given the rarity of this condition. For these reasons, this variant has been classified as Likely Pathogenic for FHD. However, it is not likely to confer risk for HLRCC. DNA CNV, SEQ-NG 20-jul-2019 Invitae (deriv. Genesia) Invitae Multi-Cancer Panel (84 genes) Multigenetic panel Breast cancer Italian - - Breast cancer 1 Jesica Ramirez-Hospital Central de Mendoza
+?/? 10 c.1431_1433dup p.(Lys477dup) Hetero no r.(?) - Unknown g.241497928_241497930dup - FH_000004 - - DNA SEQ-NG, CNV 06-mar-2024 Dasa Genómica - Genia, Laboratorio Maipu AIP, ALK, APC, ATM, ATR, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1B, CASR, CDC73, CDH1, CDK4, CDKN1B, CDKN1C, CDKN2A, CEBPA, CEP57, CHEK2, CTC1, CTNNA1, CYLD, DDB2, DICER1, DIS3L2, DKC1, EGFR, EGLN1, EPCAM, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, EXT1, EXT2, EZH2, FAN1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GAA, GALNT12, GATA2, GBA, GLA, GPC3, GREM1, HDAC2, HNF1A, HOXB13, HRAS, IDUA, KIF1B, KIT, KMT2D, LZTR1, MAX, MC1R, MDH2, MEN1, MERTK, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NHP2, NOP10, NSD1, NTHL1, PALB2, PDGFRA, PHOX2B, PMS1, PMS2, PMS2CL, POLD1, POLE, POLH, POT1, PRF1, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51C, RAD51D, RB1, RECQL4, RET, RHBDF2, RUNX1, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TERC, TERT, TINF2, TMEM127, TP53, TSC1, TSC2, TYR, VHL, WRAP53, WRN, WT1, XPA, XPC, XRCC2. Multigenetic panel Prostate cancer Italian / Spanish - - Prostate cancer 1 Silvina Sisterna-Hospital de Comunidad
Legend   How to query